Off-Label Use of Janus Kinase Inhibitors and Monoclonal Antibodies in Dermatology: A 2025–2026 Update of Indications in Developing Countries

Oana-Monica Leah, Florin Gabriel Leasu, Peter Manu, Alin Tatu, Elena Niculet, Liliana Rogozea

Open source

DOI: 10.1097/mjt.0000000000002239
Published: 2026-11
Container: American Journal of Therapeutics
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/mjt.0000000000002239,
  title = {Off-Label Use of Janus Kinase Inhibitors and Monoclonal Antibodies in Dermatology: A 2025–2026 Update of Indications in Developing Countries},
  author = {Oana-Monica Leah and Florin Gabriel Leasu and Peter Manu and Alin Tatu and Elena Niculet and Liliana Rogozea},
  year = {2026},
  journal = {American Journal of Therapeutics},
  doi = {10.1097/mjt.0000000000002239},
  url = {https://doi.org/10.1097/mjt.0000000000002239}
}

RIS

TY  - JOUR
TI  - Off-Label Use of Janus Kinase Inhibitors and Monoclonal Antibodies in Dermatology: A 2025–2026 Update of Indications in Developing Countries
AU  - Oana-Monica Leah
AU  - Florin Gabriel Leasu
AU  - Peter Manu
AU  - Alin Tatu
AU  - Elena Niculet
AU  - Liliana Rogozea
PY  - 2026
JO  - American Journal of Therapeutics
DO  - 10.1097/mjt.0000000000002239
UR  - https://doi.org/10.1097/mjt.0000000000002239
ER  -

APA

Leah, O., Leasu, F. G., Manu, P., Tatu, A., Niculet, E., & Rogozea, L. (2026). Off-Label Use of Janus Kinase Inhibitors and Monoclonal Antibodies in Dermatology: A 2025–2026 Update of Indications in Developing Countries. American Journal of Therapeutics. https://doi.org/10.1097/mjt.0000000000002239

Source records

crossref · retrieved 2026-11-07T13:06:20.604Z